Today we're speaking with Ivan Kairatov, a biopharma expert with a keen eye for how technology is reshaping research and development. He'll be helping us unpack a groundbreaking new study on SleepFM, an AI model that analyzes sleep data to predict future disease, potentially turning a simple
The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide
A groundbreaking study has decisively answered a question at the forefront of modern medicine, confirming that a cancer treatment tailored to the unique genetic fingerprint of a patient's tumor is not only possible but also significantly more effective and safe than conventional approaches.
The persistent feeling of being physically older and less resilient following a serious illness is no longer just a subjective complaint but is now understood as a tangible biological process driven by cellular damage. Many who recover from infections like influenza or COVID-19 report lingering
A significant portion of cancer patients do not respond to immunotherapy because their tumors are immunologically inactive, but a groundbreaking collaborative study from Cornell University researchers has unveiled a remarkable solution using ultrasmall fluorescent silica nanoparticles, known as
For the millions of people battling chronic nerve pain, where the lightest touch can feel like a searing burn, hope often feels distant. But a groundbreaking study is challenging the way we think about pain, shifting the focus from masking symptoms to repairing the damage at a cellular level. To
